Sharyn D Baker


Affiliation: St. Jude Children's Research Hospital
Country: USA


  1. Baker S, Verweij J, Cusatis G, van Schaik R, Marsh S, Orwick S, et al. Pharmacogenetic pathway analysis of docetaxel elimination. Clin Pharmacol Ther. 2009;85:155-63 pubmed publisher
    ..Therefore, future studies should first stratify the population on the basis of CYP3A5 genotype and then compare CYP3A activity between individuals with and without the CYP3A4*1B allele. ..
  2. Vasilyeva A, Durmus S, Li L, Wagenaar E, Hu S, Gibson A, et al. Hepatocellular Shuttling and Recirculation of Sorafenib-Glucuronide Is Dependent on Abcc2, Abcc3, and Oatp1a/1b. Cancer Res. 2015;75:2729-36 pubmed publisher